Zimmer Biomet Holdings Inc (ZBH) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket
 


Zimmer Biomet Holdings Inc   (NYSE: ZBH)


Zimmer Biomet Holdings Inc's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Zimmer Biomet Holdings Inc's ROI in the third quarter of 2026?
Zimmer Biomet Holdings Inc achieved a return on average invested assets (ROI) of 3.85 % in its third quarter of 2026, which is below Zimmer Biomet Holdings Inc's average return on investment, which stands at 4.15%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 148 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 1033 to 1774.

Definition and Formula of Return on Investment



Return On Investment (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM -0.43 % 4.72 % 8.38 % 10.24 % 9.13 %
Y / Y Net Income Change TTM -4.93 % -2.22 % 13.23 % 44.09 % 223.83 %
Investment (TTM) in Millions 20,046 19,793 19,866 20,039 21,095
Return On Investment (TTM) 3.85 % 4 % 3.75 % 3.47 % 4.03 %
ZBH's Overall Ranking # 1774 # 1033 # 1237 # 972 #
Seq. Investment Change TTM -1.3 % -0.47 % -0.04 % 1.39 % 3.81 %
Seq. Net Income Change TTM -4.91 % 6.07 % 7.9 % -12.65 % -2.19 %
Net Income (TTM) in Millions 768 807 761 705 807




Return On Investment ZBH's Ranking
Within: No.
Industry # 47
Sector # 149
Overall # 1774

Return On Investment Statistics
High Average Low
10.71 %
4.15 %
-1.66 %
(Sep 30 2010)   (Jun 30 2019)







Financial Statements
Zimmer Biomet Holdings Inc's III. Quarter Investments $ 20,046 Millions ZBH's Balance sheet
Zimmer Biomet Holdings Inc's III. Quarter Income $ 192 Millions Quarterly ZBH's Income Statement
ZBH's Income by Division See ZBH's Income by Division


ZBH Annual Return On Investment (Dec 31 2025)
2025
(Dec 31 2024)
2024
(Dec 31 2023)
2023
(Dec 31 2022)
2022
(Dec 31 2021)
2021
Total Investments in Millions 20,516 18,923 18,647 18,715 19,994
Y / Y Investment Growth 8.42 % 1.48 % -0.36 % -6.4 % -8.56 %
Net Income in Millions 705 905 1,025 232 402
Y / Y Net Income Growth -22.1 % -11.69 % 341.09 % -42.2 % -
Annual Return On Investment 3.44 % 4.78 % 5.5 % 1.24 % 2.01 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 3.44 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
ZBH's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for ZBH's Competitors
Subscribers only: Roi for Zimmer Biomet Holdings Inc's Suppliers
Subscribers only: Return On Investment for ZBH's Customers

Other Ratios
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Statistics
ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Lemaitre Vascular Inc   10.56 %
Johnson and Johnson  10.53 %
Encompass Health Corporation  10.41 %
Ani Pharmaceuticals Inc  9.61 %
Tactile Systems Technology Inc   9.27 %
Boston Scientific Corporation  9.14 %
Brightspring Health Services Inc   9.01 %
Stryker Corp  8.63 %
Pediatrix Medical Group Inc   8.37 %
Penumbra Inc  8.28 %
Medinotec Inc   8.12 %
Pacific Health Care Organization Inc  8.09 %
Quest Diagnostics Inc  8.01 %
Ge Healthcare Technologies Inc   7.60 %
Incyte Corporation  6.81 %
Lifevantage Corp  6.51 %
Merit Medical Systems Inc  6.21 %
Davita Inc   6.13 %
Black Hawk Acquisition Corporation  6.10 %
Iqvia Holdings Inc   6.09 %
Labcorp Holdings Inc   6.07 %
Pacs Group Inc   5.95 %
Ensign Group Inc  5.94 %
Amneal Pharmaceuticals Inc   5.59 %
Sotera Health Company  5.43 %
Henry Schein Inc   5.27 %
Abbott Laboratories  5.14 %
Haemonetics Corporation  4.85 %
Teleflex Incorporated  4.81 %
Lifestance Health Group Inc   3.71 %


Date modified: 2026-11-07T13:17:52+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.